Gross failure rates and failure modes for a commercial AI-based auto-segmentation algorithm in head and neck cancer patients.
Journal:
Journal of applied clinical medical physics
Published Date:
Jan 23, 2024
Abstract
PURPOSE: Artificial intelligence (AI) based commercial software can be used to automatically delineate organs at risk (OAR), with potential for efficiency savings in the radiotherapy treatment planning pathway, and reduction of inter- and intra-observer variability. There has been little research investigating gross failure rates and failure modes of such systems.